During cancer progression, epithelial cells can undergo EMT to migrate, invade, and proliferate and vimentin overexpression can be a sign of the progression of cancerous events (46), including breast cancer, prostate cancer, endometrial cancer, or gastrointestinal tract tumors. This evidence concerns the gene VIM and breast carcinoma.